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ABSTRACT 
Objectives: The aim of this study is to investigate the effect of gum arabic (GA) as reducing agent and stabilizer in gold nanoparticle (AuNP) 
formulation and the antioxidant activity of GA-AuNP.  
Methods: Gold nanoparticles (AuNPs) were synthesized by reducing hydrogen tetrachloroaurate (HAuCl4
Results: The AuNPs formed using gum arabic as both the reducing agent and stabilizer, using sodium borohydride as the reducing agent with gum 
arabic as the stabilizer, and using sodium borohydride alone had particle sizes of 6.52 ± 0.66 nm, 4.045 ± 0.99 nm, and 55.82 ± 39.87 nm, 
respectively. The percentages oxidation inhibition for these particles were 74.39 ± 0.255%, 73.51 ± 0,251%, and 72.63 ± 0.567%, respectively.  
) via three techniques: using gum arabic 
(GA-AuNP), using sodium borohydride (NaBH4) with GA as a stabilizing agent (GA-AuNP), and using NaBH4 (AuNP). These nanoparticles were 
characterized via UV-VIS spectroscopy, TEM, AFM, and PSA. The antioxidant activity of the AuNPs was measured via the DPPH method. Their 
physical stability was determined using a UV-VIS spectrophotometer over 5 weeks during storage at room temperature.  
Conclusion: Gum arabic (GA) was successfully acted as reducing and stabilizing agent to the gold nanoparticle (AuNP) and increase the percentage 
oxidation inhibition of AuNP. The stability test indicated that the GA-AuNP were physically stable for at least 5 weeks. 
Keywords: Antioxidant activity, Gold, Nanoparticle, Gum arabic, Sodium borohydride. 
 
INTRODUCTION 
Nanotechnology has been applied to topical and transdermal 
applications such as preparing gold nanoparticles (AuNPs). Gold has 
been used as a cosmetic material because it is poorly oxidized, inert, 
and nontoxic and has antioxidant and anti-aging properties [1]. 
Several studies have shown that AuNPs have antioxidant activity 
that significantly decreased the oxidative stresses that form reactive 
oxygen species (ROS) [2]. 
AuNPs are generally unstable because of their high surface energy. A 
suitable stabilizer should be added to prevent aggregation [3]. 
Preparing AuNPs requires a stabilizer to control growth and prevent 
aggregation. One commonly used stabilizer is gum arabic (GA).  
GA can be used as both a stabilizing and reducing agent. This 
property has been used to synthesize both nonradioactive and 
radioactive AuNPs with steric stability. Based on the information 
above, this study manufactured and characterized AuNPs using GA 
as a stabilizer. 
MATERIALS AND METHODS 
Materials 
Au foil (Sigma-Aldrich, Germany), gum arabic (Sigma-Aldrich), 
sodium borohydride (Merck, Germany), aqua bidestilata (IPHA, 
Indonesia), 1,1-diphenyl-2-picril-hydrazil (DPPH; Sigma-Aldrich), 
bovine serum albumin (Sigma-Aldrich), methanol (Sigma-Aldrich), 
phosphate buffer saline (IPHA), PD-10 column (GE Health Care, 
England), sodium dibasic phosphate (Merck), and sodium phosphate 
monobasic (Merck) were obtained. 
Preparation of the HAuCl, NaBH4
A 0.002 M HAuCl solution was prepared by dissolving 20.1 mg of Au 
foil in hot aqua regia (HCl (aq):HNO3(aq) = 3:1). This solution was 
heated, and 10 mL of an aqua pro injection was added.  
 and GA solutions 
The heating process and aqua pro injection were performed three 
times. The final solution was added to a 0.01 M HCl solution to 
obtain the 0.002 M HAuCl solution. 
A 0.1 M NaBH4
Preparation of AuNPs using GA as both the stabilizer and 
reductor 
 reduction solution was prepared by dissolving 0.038 
g of solid NaBH4 in 10 mL of the aqua pro injection. This solution 
needed to be freshly prepared before use. A concentration of 0.02 M 
was reached by diluting with aqua pro injection. The gum arabic 
solution was prepared by dispersing 0.6088 g of GA into up to 50.0 
mL of aqua pro injection. 
An 8.20 mL aliquot of the GA solution and 0.3 mL aliquot of the aqua 
pro injection were heated to 55°C and continuously stirred. To this 
hot GA solution, 1.5 mL of the 0.002 M HAuCl solution was added 
with continuous stirring. Once the solution had become reddish 
purple, the stirring was continued for 1 minute without heating. 
Preparation of AuNPs using GA as the stabilizer and NaBH4 as 
the reductor  
An 8.20 mL aliquot of the GA solution and 0.25 mL aliquot of the 
aqua pro injection were heated to 55°C with continuous stirring. To 
this hot GA solution, 1.5 mL of 0.002 M HAuCl was added with 
continuous stirring for 1 minute. Next, 0.05 mL of 0.02 M NaBH4 was 
added with continuous stirring. Once the solution had become 
reddish purple, the stirring was continued for 1 minute without 
heating.  
Preparation of AuNPs without stabilizer 
An 8.20 mL aqua pro injection was heated to 55°C and continuously 
stirred. To the warm aqua pro injection, 1.5 mL of 0.002 M HAuCl 
was added with continuous stirring for 1 minute. Next, 0.05 mL of 
0.02 M NaBH4 was added with continuous stirring. Once the solution 
had become reddish purple, the stirring was continued for 1 minute 
without heating. 
Purification of AuNPs  
The purification process used size exclusion chromatography (SEC) 
with a Sephadex G-25 medium (PD-10) column. Before the 
purification, the column was eluted using phosphate buffered saline 
(PBS), pH 7.5, saturated with 1.0 mL of 0.5% bovine serum albumin 
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(BSA), and then rinsed with 0.01 M PBS, pH 7.5. After the column was 
conditioned, 1.0 mL of the AuNP sample was poured into the column and 
eluted using 0.01 M PBS, pH 7.5. Fractions were collected every 1.0 mL.  
Characterization of the AuNPs  
Each fraction was collected, characterized, and analyzed. The 
physical appearance of the AuNPs, including their morphology, 
color, and odor, was characterized. The UV-Vis absorbance spectrum 
of GA, HAuCl, and the four preparations of AuNPs were collected and 
analyzed at the wavelengths from 400-800 nm.  
Transmission electron microscopy (TEM) was used to characterize 
the morphology of the AuNPs. The zeta potentials of the AuNPs were 
measured via electrophoretic light scattering (ELS) using a Delsa 
Nano C particle size analyzer (PSA) at scattering angles of 15°, 30°, 
and 60° to measure the electrophoretic mobility.  The polydispersity 
index was measured via photon correlation spectroscopy (PCS) 
using a Delsa Nano C PSA via the same procedure.The AuNP surface 
topographies were observed using atomic force microscopy (AFM). 
The optimum characterization conditions for the AuNPs were 2000 
rpm for 30 seconds. 
 
Table 1: Reaction Conditions for Preparing the Gold Nanoparticles 
Preparation GA (ml) Precursor 
0.002 M HAuCl4 
Reductor 
(mL) 0.02 M NaBH4
Reaction Time (hours) 
 (mL) 
Solution Color Ratio 
GA-HAuCl 8.2 4 1.5 - 4 Reddish purple 0.13: 1 
GA-HAuCl4-NaBH 8.2 4 1.5 0.05 4 Reddish purple 0.13: 1: 0.3 
GA-HAuCl4-NaBH 0.5  4 2.5 0.05 4 Reddish purple 0.005: 1: 0.3 
HAuCl4-NaBH - 4 1.5 0.05 4 Reddish purple 1: 0.3 
 
Antioxidant activity of the AuNPs 
DPPH was prepared as a control solution by dissolving DPPH in 
methanol to obtain a 40 ppm DPPH solution. A 2.0 mL aliquot of 
methanol was added to 2.0 mL of this solution and placed into a 
container protected from light. This mixture was homogenized by 
vortexing for 10 seconds before incubating at 37°C for 30 minutes. 
Its absorbance spectrum was measured using a UV-Vis 
spectrophotometer across the wavelengths of 400-800 nm. The 
maximum wavelength was then determined. 
The antioxidant activities of the sample AuNP solutions were 
determined using the above procedure at the maximum wavelength. 
Vitamin C was used as a positive control [4,5].  
The absorbance of the sample solution was used to calculate the 
inhibition percentage via the formula below: 
Inhibition percentage =  
absorbance of control solution –  absorbance of sample
absorbance of control solution
 𝑥𝑥 100% 
RESULTS AND DISCUSSION 
Preparation and purification of the gold nanoparticles 
The first step in the preparation of the AuNPs was to dissolve the Au 
foil in aqua regia (HCl (p):HNO3 (p) = 3:1) because Au only dissolves 
in this solution. Nitric acid, a strong oxidizer, oxidizes the Au foil to 
Au3+. The resulting Au3+ reacts with Cl- to form AuCl3. The HAuCl4 
The purification process was performed via SEC with a Sephadex G-
25 medium (PD-10) column. A total of 10 fractions were obtained. 
Fractions 4 and 5 showed the highest absorbances, 0.63574 at a 
wavelength of 535 nm and 0.52857 at a wavelength of 536 nm, 
respectively. This purification method is based on separation by 
molecular size. The molecular weights of HAuCl4, GA, and NaBH4 are 
339.7865, ~250,000, and 37.8325, respectively.  
AuNPs were prepared using GA as both the reductor and stabilizer, 
sodium borohydride as the reductor with gum arabic as the 
stabilizer and sodium borohydride as the reductor without a 
stabilizer. The UV-Vis spectra showed the Au absorbance at 
wavelength 290 nm disappeared, which indicated that the Au was 
reduced [6]. The AuNPs exhibited absorbance at wavelengths from 
500 – 550 nm. Higher AuNP solution concentrations had higher 
absorbances.  
Larger molecules elute before smaller molecules. This purification 
was suitable for separating the AuNP-GA complexes, free AuNPs, and 
sodium borohydride.  
Characterization of the gold nanoparticles 
The obtained nanoparticle solutions were reddish purple and had no 
odor, as shown in Figure 1. 
 
Fig. 1: Physical appearance of (a) gum arabic (GA) – gold 
nanoparticles (GA-HAuCl4-NaBH4 0.005:1:0.3), (b) purified GA – 
gold nanoparticles (GA-HAuCl4-NaBH4 0.005:1:0.3) with GA as a 
stabilizer, (c) GA – gold nanoparticles (GA-AuNP 0.13:1:0.3) 
with GA as a stabilizer, (d) purified GA – gold nanoparticles (GA-
HAuNP 
 
0.13:1:0.3) with GA as a stabilizer, (e) GA – gold 
nanoparticles (GA-AuNP) with GA as both a stabilizer and 
reductor, and (f) unstabilized gold nanoparticles (AuNP). 
All the AuNPs were prepared as clear solutions, which indicates that 
the Au was homogenously dispersed with very small particle sizes. 
Therefore, the particles cannot be observed by the naked eye. When 
Au3+ was perfectly reduced to Au0
Figure 1 shows that the AuNPs using the GA stabilizer had a more 
intense reddish purple color. The solution turned clear after 
purification. This result indicates that the purification method 
successfully separated the AuNPs from the other compounds. The 
AuNPs with GA as both a stabilizer and reductor had a less intense 
reddish purple color. This result was caused by the lower reductive 
activity of GA relative to a chemical reductor. The unstabilized 
AuNPs were purple because fewer AuNPs were produced in the 
solution without a stabilizer. The varying solution colors indicated 
that the different protocols produced AuNPs with different sizes. 
, the clear yellow solution became 
reddish purple. This color developed due to surface plasmon 
resonance (SPR), which is a specific property of AuNPs. The 
maximum AuNP absorbance occurred at wavelengths from 520-565 
nm, which correspond to green and purple.  
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Fig. 2: Morphology of (a) gum arabic (GA) – gold nanoparticles 
(GA-AuNP 0.005:1:0.3) with GA as a stabilizer, (b) purified GA – 
gold nanoparticles (GA-AuNP 0.005:1:0.3) with GA as a 
stabilizer, (c) GA – gold nanoparticles (GA-AuNP 0.13:1:0.3) 
with GA as a stabilizer, (d) purified GA – gold nanoparticles (GA-
AuNP 0.13:1:0.3) with GA as a stabilizer, (e) GA – gold 
nanoparticle (GA-AuNP 0.13:1) with GA as both a stabilizer and 
reductor, and (f) unstabilized gold nanoparticles (AuNP) using 
transmission electron microscopy (TEM) with 40,000× 
magnification. 
 
Figure 2 shows a TEM micrograph of the AuNPs. The GA-HAuCl4-
NaBH4
The surface characteristics affect the stability and cell membrane 
interactions of nanoparticles. The nanoparticle zeta potentials are 
commonly used to characterize the charge of a nanoparticle surface. 
In the electric double layer theory, the zeta potential predicts the 
stability of a colloid system. High zeta potentials (either positive or 
negative) indicate a stable colloidal system that prevents particles 
from aggregating due to electrostatic repulsion between the 
particles. In general, particles with zeta potentials above +30 mV or 
below -30 mV are predicted to be stable during storage and 
prevented from undergoing particle aggregation. 
The polydispersity indexes for GA-AuNPs using GA as a stabilizer 
(0.005:1:0.3), purified GA-AuNPs using GA as a stabilizer 
(0.005:1:0.3), GA-AuNPs using GA as a stabilizer (0.13:1:0.3), 
purified GA-AuNPs using GA as a stabilizer (0.13:1:0.3), GA-AuNPs 
using GA as both a stabilizer and reductant, and unstabilized AuNPs 
were 0.511, 0.505, 0.742, 0.703, 0.507, and 0.708, respectively. The 
GA-AuNP samples using GA as both a stabilizer and reductant 
exhibited the lowest polydispersity index. This result indicated that 
the AuNPs formed were monodisperse without particle aggregation. 
In addition, the SEC purification process made the GA-AuNP system 
more monodisperse than the unpurified samples. The polydispersity 
index is a parameter detailing the particle size distribution of the 
nanoparticle system with values of 0.01 to 0.7 indicating 
monodisperse particles and values above 0.7 indicating a wide 
particle size distribution. The polydispersity index reflects the 
stability of a nanoparticle system, with increasing values indicating 
increasing particle aggregation. A monodisperse nanoparticle 
system has a narrow particle size and contains stable nanoparticles 
with fewer aggregates. A qualitative analysis of the infrared 
spectrum of the GA-AuNP samples searched for interactions 
between the HAuCl and GA and aimed to prove that GA protects the 
AuNPs. The infrared spectrum for GA exhibits primary peaks at 1049 
and 1413 cm
 ratio of 0.005:1:0.3 with GA as the stabilizer produced 
spherical particles with nonhomogeneous sizes. Due to the low 
stabilizer concentration, the nanoparticles tended to aggregate. 
Unstabilized AuNPs (Fig 2.f) were larger than the other prepared 
AuNPs. The absence of a stabilizer resulted in particle aggregation. 
This result demonstrates that there is a correlation between the 
solution color and the AuNP size.  
The AuNP size distribution was determined using a particle size 
analyzer. The particle size distributions for the GA-AuNPs using the 
GA stabilizer (0.005:1:0.3), the purified GA-AuNPs using the GA 
stabilizer (0.005:1:0.3), GA-AuNPs using GA as a stabilizer 
(0.13:1:0.3), the purified GA-AuNPs using GA as a stabilizer 
(0.13:1:0.3), GA-AuNPs using GA as a stabilizer and reductor, and 
unstabilized AuNPs were 4.045 ± 0.99 nm, 4.83 ± 1.03 nm, 4.87 ± 
1.68 nm, 12.12 ± 3.36 nm, 6.52 ± 0.66 nm, and 55.82 ± 39.87 nm, 
respectively. These values indicate that the formed AuNPs were less 
than 100 nm in size. GA effectively reduced the AuNP size. These 
results show that the GA-AuNP sample using GA as both the 
stabilizer and reducing agent still formed AuNPs smaller than 100 
nm without using a chemical reductant. 
The zeta potential of the AuNPs was determined using an 
electrophoretic particle analyzer with ELS. The zeta potentials of the 
GA-AuNPs using GA as a stabilizer (0.005:1:0.3), purified GA-AuNPs 
with GA as a stabilizer (0.005:1:0.3), GA-AuNP using GA as a 
stabilizer (0.13:1:0.3), purified GA-AuNPs using GA as a stabilizer 
(0.13:1:0.3), GA-AuNPs using GA as both a stabilizer and reductant, 
and unstabilized AuNPs were -26.4 ± 1.62, -28.4 ± 1.30, -30.1 ± 2.16, 
25.8 ± 1.53, -31.9 ± 1.88, and -39.3 ± 0.46, respectively. 
-1 (bound C-O), 1060 cm-1 (C-O), 1616 cm-1 (C-O and N-
H), and 3000-3600 cm-1
 
 (free O-H).  
The AuNP spectra were identical to the GA spectrum. This result 
suggests that GA is present on the AuNP surface. Thus, the high 
AuNP stability may be due to protection by GA. 
Metal nanoparticles tend to aggregate due to strong interparticular 
forces pulling the particles closer together to form larger particle 
clusters over time. Although gold nanoparticles are more stable than 
other nanoparticles, they still tend to aggregate. 
The absorbance and maximum wavelength measurements showed a 
relationship over time. The stability of the AuNPs was evaluated 
using the change in wavelength and maximum absorbance 5 weeks 
after synthesis. 
The λ max measurements shifted with increasing storage time. This 
condition was caused by the large AuNP surface energy, which is 
unstable and easily leads to aggregation. Therefore, increasing the 
time resulted in the formation of larger particles, and thus the λ max 
underwent a bathochromic shift. The absorbance showed a similar 
trend with the absorbance values increasing to a maximum within 4 
hours before decreasing again. This increased absorbance indicated 
that more AuNPs were formed, whereas a decreased absorbance 
would indicate that the AuNPs agglomerated into larger particles, 
decreasing the transmitted light. 
The AFM analysis of the AuNPs indicated that the particle size was ~ 
20 nm. The observed AuNP surface profile of the AuNPs using GA as 
a stabilizer is shown in Figure 3. The sample surface area was 500 
nm × 500 nm and 1 µm × 1 µm. The AFM particle size analysis for the 
AuNPs is slightly different from the results measured using PSA. This 
difference may result from a textural change smaller than the tip 
size, which would prevent properly recording small positional shifts 
of the cantilever toward the normal (on the order of tens of 
nanometers). 
Fig. 3: Topography of Formula E gold nanoparticles using 
atomic force microscopy (AFM) with scan area of (a) 500 nm × 
500 nm and (b) 1 µm × 1 µm.
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Table 2: Inhibition Activity of Gold Nanoparticles 
Preparation Concentration (µg/ mL) Absorbance at 516 nm Inhibition (%) 
Control Sample Sample + DPPH 
GA-HAuCl4-NaBH 59.1 4 0.453 1.136 1.256 73.51±0.221 
GA-HAuCl 59.1 4 0.453 0.683 0.799 74.39±0.255 
HAuCl4-NaBH 59.1 4 0.453 0.202 0.326 72.63±0.567 
 
Antioxidant activity test of the AuNPs 
The scavenging of free radicals by DPPH was used in this study to 
measure the antioxidant activity. During this process, the test 
substance donates a hydrogen atom to the DPPH free radical, thus 
reducing DPPH to the stable non-radical compound 1,1-diphenyl-2-
picril-hydrazine.  This transition is characterized by a color change 
from purple to pale yellow or colorless. Testing the antioxidant 
activity of the AuNPs revealed that the percent inhibition was 73.51 
± 0.221% for AuNPs using GA as a stabilizer, 74.39 ± 0.255% for 
AuNPs using GA as both a stabilizer and reductant, and 72.63 ± 
0.567% for AuNPs without any stabilizer. These results suggest that 
the AuNPs had good radical scavenging capabilities.The percent 
inhibitions obtained for the three nanoparticle variations were 
similar. However, the unstabilized AuNPs had the lowest percent 
inhibition. This reduced inhibition likely results from the reduced 
particle surface area available to scavenge the DPPH radicals due to 
the presence of large clusters in this sample. 
CONCLUSIONS  
The above results lead to the following conclusions: 
1. Three AuNP variations were prepared using GA as a stabilizer, GA as 
both a stabilizer and reductant, and as an unstabilized solution, which 
yielded spherical AuNPs of 4.045 ± 0.99 nm, 6.52 ± 0.66 nm, and 55.82 ± 
39.87 nm, respectively, in size that were stable for up to 5 weeks. 
2. The percentage oxidation inhibition was 73.51 ± 0.221% for the 
GA-stabilized AuNPs, 74.39 ± 0.255% for the AuNPs using GA as 
both a stabilizer and reductant, and 72.63 ± 0.567% for the 
unstabilized AuNPs. 
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